Real-time data

Listing exchange

NASDAQ Stock Exchange

Price

$1.87

Day High

$1.87

Day Low

$1.87

Day Open

$1.87

Volume

297

Day Change

-2.67%

Latest news data for ADAG

Adagene Announces Interim Data Demonstrating Safety and Confirmed Clinical Responses of Anti-CTLA-4 SAFEbody® ADG126 up to 10 mg/kg with Repeat Cycles in Combination with Anti-PD-1 Therapy from Dose E

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday’s Mid-Day Session - Adagene (NASDAQ:ADAG), Adobe (NASDAQ:ADBE)

ADAG stock gains on clinical trial collaboration with Roche (NASDAQ:ADAG)

Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4 SAFEbody® ADG126 in Combination with Roche’s Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Appoints Cuong Do to Board of Directors and Audit Committee

Adagene Announces Clinical Data at SITC 2022 on Anti-CTLA-4 NEObody™, ADG116, Showing Differentiated Safety and Anti-tumor Activity in Heavily Pre-treated Patients with Difficult-to-Treat Tumors

Adagene Inc. (NASDAQ:ADAG) Sees Significant Increase in Short Interest

Adagene Announces Poster Presentations on Anti-CTLA-4 NEObody™, ADG116, at Upcoming Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in November, Business News

Adagene Inc. (NASDAQ:ADAG) Sees Significant Drop in Short Interest

Adagene Inc. (NASDAQ:ADAG) Short Interest Down 21.1% in August

News sentiment (24 hrs)

Intraday data

Historical data

maximum of 5 years displayed, 40+ years of data available via API